La Jolla Pharmaceutical (NASDAQ:LJPC) Now Covered by StockNews.com

StockNews.com began coverage on shares of La Jolla Pharmaceutical (NASDAQ:LJPC – Get Rating) in a research note issued to investors on Thursday. The firm set a “buy” rating on the biopharmaceutical company’s stock. Separately, Zacks Investment Research downgraded La Jolla Pharmaceutical from a “buy” rating to a “hold” rating in a report on Wednesday, January […]

Related Keywords

San Diego ,California ,United States ,La Jolla , ,Marshall Wace ,Zacks Investment Research ,Jolla Pharmaceutical Co ,Jolla Pharmaceutical Company Profile Get Rating ,Get Rating ,Jolla Pharmaceutical ,Minvest Partners ,Capital Management ,Jolla Pharmaceutical Company Profile ,La Jolla Pharmaceutical ,Nasdaq Ljpc ,Ljpc ,Medical ,Initiated Coverage ,Stocknews Com ,